OUR MISSION
develop new therapies for cancer and related diagnostics,
follow-up the onset of the disease, check the efficacy of the treatment
- OUR HISTORY
Oncoxx Biotech S.r.l is a Cancer Biotech Company founded in 2012 as partnership between Chieti University Research Center and private entrepreneurs.
-
Business context: the cost of developing a new drug is 1 billion $, in a time frame of 15 years
-
Oncoxx Biotech is competitive in the development of novel anti-cancer drugs
-
Oncoxx Biotech academic settings allow competitive R&D and clinical experimentation costs
-
Oncoxx Biotech has already generated two new anti-Trop-2 monoclonal antibodies as anti-cancer agents
-
Antibodies are efficient against cancer
- OUR TEAM
Saverio Alberti
President, CEO
Chieti University Oncological Patology Researcher,
-
Emanuela Guerra
-
Valeria Relli
-
Antonella D’ Amore
-
Chiara Pedicone
-
Valentina Lucchini
Collabs
-
Marco Trerotola
-
Rossano Lattanzio
-
Mauro Piantelli